You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 3, 2024

Details for Patent: 11,141,540

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 11,141,540 protect, and when does it expire?

Patent 11,141,540 protects SYMJEPI and is included in one NDA.

This patent has thirty-two patent family members in seventeen countries.

Summary for Patent: 11,141,540

Title:	Syringe devices
Abstract:	Described herein are syringe devices comprising a syringe including a therapeutic dose of at least one drug and a stopper. The syringe is housed and/or placed in an encasement. The plunger assembly can include a plunger, an actuator, and a spacer, wherein the plunger assembly is configured to move the stopper a predetermined distance without a user touching the plunger. Methods of assembling and using the syringe devices are also described.
Inventor(s):	Rolfs; Bryan E. (St. Paul, MN), Flather; Mark J. (San Diego, CA), Daniels; Karen K. (San Diego, CA), Moll; Thomas (San Diego, CA)
Assignee:	Adamis Pharmaceuticals Corporation (San Diego, CA)
Application Number:	15/754,569
Patent Claim Types: see list of patent claims	Use; Compound; Delivery; Device;

Drugs Protected by US Patent 11,141,540

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Adamis Pharms Corp	SYMJEPI	epinephrine	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	207534-002	Sep 27, 2018		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial	Y			A METHOD FOR ADMINISTERING A THERAPEUTIC DOSE OF EPINEPHRINE	⤷ Try a Trial
Adamis Pharms Corp	SYMJEPI	epinephrine	SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS	207534-001	Jun 15, 2017		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y			A METHOD FOR ADMINISTERING A THERAPEUTIC DOSE OF EPINEPHRINE	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 11,141,540

PCT Information
PCT Filed	March 17, 2016	PCT Application Number:	PCT/US2016/022956
PCT Publication Date:	March 02, 2017	PCT Publication Number:	WO2017/034618

International Family Members for US Patent 11,141,540

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2016313110	⤷ Try a Trial
Australia	2019203244	⤷ Try a Trial
Australia	2020202668	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.